Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1486 (LINC01486) is a member of the lincRNA class, consisting of autonomously transcribed non-coding RNA longer than 200 nucleotides located in a genomic region outside annotated protein-coding genes. LINC01486’s full sequence and locus are registered in the NCBI and Ensembl gene databases. Long intergenic non-coding RNAs, including LINC01486, are broadly involved in regulation of gene expression through chromatin modulation, transcriptional regulation, and RNA processing, though the specific biological function of LINC01486 itself remains uncharacterized in current literature[1][3][5][7]. There are no reported associations with diseases, drug interactions, or established roles as a therapeutic target at present[1][3][5]. Key points: - LINC01486 is correctly classified and annotated. - It is a non-coding RNA, not a canonical therapeutic target. - No associations with disease, drugs, or biomarkers reported in current databases[1][3][5]. - Its biological function is inferred based on the typical properties of lincRNAs, not on direct experimental data for LINC01486.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1486 (LINC01486).